Skip to main content
Clinical Trials/RBR-34d3jv2
RBR-34d3jv2
Recruiting
Phase 1

Interventional clinical protocol for assessing the therapeutic efficacy of 50% Autologous Serum Eye Drops in the treatment of corneal epithelial defects in Inflammatory ocular surface diseases

niversidade Federal de São Paulo - UNIFESP/EPM0 sitesNovember 27, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversidade Federal de São Paulo - UNIFESP/EPM
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 27, 2023
End Date
December 1, 2024
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal de São Paulo - UNIFESP/EPM

Eligibility Criteria

Inclusion Criteria

  • Age 18 to 80 years. Both genders. Confirmed diagnosis of one of the following pathologies: Sjögren 's syndrome, Moderate to severe non\- Sjögren's dry eye, Stevens\-Johnson syndrome, Graft versus host disease, Neurotrophic keratitis, Neurotrophic pain. Presence of corneal epithelial defect without improvement after treatment with preservative\-free lubricating eye drops for at least 14 days. Absence of active infection on the ocular surface. No recent use of the following medications or performance of the following procedures: anticoagulants/ anti\- platelet aggregation, blood product eye drops in the last 3 months, eye surgery in the last 6 months. Does not present any of the following conditions: poorly controlled systemic disease, active infection or advanced\-stage cancer, pregnancy or breastfeeding. There are no contraindications to blood donation: positive serology for HIV I and II or HTLV 1/2 or hepatitis B or hepatitis C or syphilis or Chagas disease according to Ordinance 158 of 02/04/2016 of the Ministry of Health – Brazil, anemia (hemoglobin level \< 11\.0 mg/dl) or thrombocytopenia (platelet level \< 150 x 10 9 /L). Ability to adhere to the treatment and follow\-up protocol during the study period and provide written consent for participation

Exclusion Criteria

  • Diagnosis of active corneal infection. Pregnancy diagnosed after beginning the protocol. Loss of clinical follow\-up. Incorrect adherence to treatment, with application of less than 70% of the expected daily dose or remaining without use for more than one full day a week. Inadequate storage and care of eye drops. Need for other interventions to treat epithelial defect

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Clinical observational study for evaluation of the therapy outcome and the dependency of the outcome on parameters as reconstruction type and/or vitamin D level in OMS tumor patients in need of intra-oral tumor resection and reconstructioC01C02C03C04C05C06C44C40C41C07C08C09C10C11C12C13C14Malignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueMalignant neoplasm of gumMalignant neoplasm of floor of mouthMalignant neoplasm of palateMalignant neoplasm of other and unspecified parts of mouthOther malignant neoplasms of skinMalignant neoplasm of bone and articular cartilage of limbsMalignant neoplasm of bone and articular cartilage of other and unspecified sitesMalignant neoplasm of parotid glandMalignant neoplasm of other and unspecified major salivary glandsMalignant neoplasm of tonsilMalignant neoplasm of oropharynxMalignant neoplasm of nasopharynxMalignant neoplasm of piriform sinusMalignant neoplasm of hypopharynxMalignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
DRKS00025841niversitätsklinikum derGoethe-Universität Frankfurt am MainKlinik für Mund-, Kiefer- und Plastische Gesichtschirurgie100
Completed
Phase 3
Maha analuruva chooranam (internal) and Chennagarapattai ennai (external)for the management of Baalavatham(Paresis) in childreHealth Condition 1: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhere
CTRI/2021/08/035549ational Institute of Siddha30
Recruiting
Not Applicable
Clinical observational trial for evaluation of the efficiency of different defect treatments after resection of basal cell carcinoma in face and head areaC44Other malignant neoplasms of skin
DRKS00019812niversitätsklinikum der Goethe-Universität Frankfurt am Main Klinik für Mund-, Kiefer- und Plastische Gesichtschirurgie1,000
Completed
Phase 3
thaamani Nei(Internal) and Nellikkai thylam (External) in the management of Mantha Sanni (Autism spectrum disorder)
CTRI/2021/08/035524ational Institute of Siddha
Recruiting
Not Applicable
Evaluation of suitable criteria for the therapy of uterine fibroids by MR-guided high-intensity focused ultrasound (MR-HIFU)D25.0D25.1Submucous leiomyoma of uterusIntramural leiomyoma of uterus
DRKS00013526Klinikum der Universität München, Campus Großhadern75